Common Stock, Shares, Outstanding of Arcturus Therapeutics Holdings Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arcturus Therapeutics Holdings Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Arcturus Therapeutics Holdings Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 28,414,000, a 5.2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Arcturus Therapeutics Holdings Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 28,414,000 +1,414,000 +5.2% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 27,235,000 +151,000 +0.56% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 27,148,000 +106,000 +0.39% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q4 2024 27,000,000 +172,000 +0.64% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 27,084,000 +361,000 +1.4% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 27,042,000 +468,000 +1.8% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 27,121,000 +566,000 +2.1% 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 26,828,000 +273,000 +1% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 26,723,000 +231,000 +0.87% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 26,574,000 +140,000 +0.53% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 26,555,000 +148,000 +0.56% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 26,555,000 +183,000 +0.69% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 26,492,000 +143,000 +0.54% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 26,434,000 +107,000 +0.41% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 26,407,000 +88,000 +0.33% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 26,372,000 +180,000 +0.69% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 26,349,000 +1,876,000 +7.7% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 26,327,000 +5,717,000 +28% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 26,319,000 +11,162,000 +74% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 26,192,000 +11,054,000 +73% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 24,473,000 +9,347,000 +62% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 20,610,000 +7,490,000 +57% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 15,157,000 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 15,138,000 +4,419,000 +41% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 15,126,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 13,120,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 10,719,000 31 Dec 2018 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.